Drug-resistant bacteria are one of the most urgent health challenges of our time, affecting people, animals, and the ...
While providers aren’t required to follow OIG recommendations, a compliance program based on their guidance can spare ...
Amlitelimab, an OX40 ligand–targeting therapy that modulates T-cell-mediated inflammation without causing cell depletion, ...
New York City-based NYC Health + Hospitals has launched the Special Pathogens Biopreparedness Map, a tool designed to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results